{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:13:53Z","timestamp":1740147233838,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study analyzed the long-term survival of dialysis patients undergoing AVR using the Japanese National Clinical Database with additional survival data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>De-novo AVR for dialysis-dependent patients between 2010 and 2012 who were registered in the Japan Cardiovascular Surgery Database were included. Concomitant aortic surgery and transcatheter aortic valve replacement were excluded. An additional questionnaire was sent to each hospital regarding the underlying kidney disease, the duration of dialysis initiation to the surgery, and clinical outcomes. The Kaplan\u2013Meier survival curve was descriptively shown for all cohorts and each renal pathology. Furthermore, we compared the incidence of bioprosthetic valve failure in patients who were\u2009&lt;\u200965\u00a0years old (group Y) and \u226765\u00a0years old (group O).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of these 1529 patients, diabetic nephropathy was 517, chronic glomerulonephritis was 437, and renal sclerosis was 210, regarding renal pathology. 1, 3, and 5-year survival in each pathology was 78.4%, 58.6%, 45.9% in diabetic nephritis, 78.8%, 68.4%, 58.2% in chronic glomerulonephritis, 79.0%, 67.8%, 52.1% in renal sclerosis, and 74.4%, 62.6%, 49.2% in others. Active infectious endocarditis was more prevalent in group Y (O 2.7% vs. Y 9.6%). The incidence of bioprosthetic valve failure requiring re-hospitalization was too small to analyze. 1, 3, and 5-year survival was 76.0%, 63.4%, 49.2% in group O and 74.3%, 64.2%, and 47.7% in group Y.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Long-term survival of AVR for dialysis-dependent was higher in patients with chronic glomerulonephritis and lower in patients with diabetic nephritis than in other pathologies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11748-024-02011-3","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:11:09Z","timestamp":1709813469000},"page":"577-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Descriptive analysis of long-term survival after aortic valve replacement for dialysis patients: importance of renal pathologies and age"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-4482","authenticated-orcid":false,"given":"Kaoru","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Matsumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2011_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/ejcts\/ezt157","volume":"44","author":"A Saito","year":"2013","unstructured":"Saito A, Miyata H, Motomura N, Ono M, Takamoto S, Japan Cardiovascular Surgery Database O. Propensity-matched analysis of bilateral internal mammary artery vs single internal mammary artery in 7702 cases of isolated coronary artery bypass grafting. Eur J Cardio-Thorac Surg. 2013;44:711\u20137.","journal-title":"Eur J Cardio-Thorac Surg"},{"issue":"166\u201373","key":"2011_CR2","volume":"157","author":"S Ohira","year":"2019","unstructured":"Ohira S, Miyata H, Yamazaki S, Numata S, Motomura N, Takamoto S, et al. Deep sternal wound infection after bilateral internal thoracic artery grafting: Insights from a Japanese national database. J Thorac Cardiovasc Surg. 2019;157(166\u201373): e1.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"2011_CR3","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1253\/circj.CJ-21-0444","volume":"85","author":"H Tsukihara","year":"2021","unstructured":"Tsukihara H, Motomura N, Takamoto S. Audit-based quality validation of the Japan cardiovascular surgery database. Circ J. 2021;85(11):2014\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-21-0444.","journal-title":"Circ J"},{"issue":"5","key":"2011_CR4","first-page":"15","volume":"2015","author":"N Hanafusa","year":"2011","unstructured":"Hanafusa N, Nakai S, Iseki K, Tsubakihara Y. Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl. 2011;2015(5):15\u201322.","journal-title":"Kidney Int Suppl"},{"key":"2011_CR5","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","volume":"69","author":"R Saran","year":"2017","unstructured":"Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69:A7\u20138.","journal-title":"Am J Kidney Dis"},{"key":"2011_CR6","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","volume":"71","author":"R Saran","year":"2018","unstructured":"Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71:A7.","journal-title":"Am J Kidney Dis"},{"key":"2011_CR7","unstructured":"Matsuura K, Yamamoto H, Miyata H, Matsumiya G, Motomura G. Mechanical vs bioprosthetic aortic valve replacement in patients on dialysis: long-term outcomes. Ann Thoraic Surg. 2023;S0003-4975(23)00013-9."},{"key":"2011_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004961","author":"Y Kawase","year":"2017","unstructured":"Kawase Y, Taniguchi T, Morimoto T, Kadota K, Iwasaki K, Kuwayama A, et al. Severe aortic stenosis in dialysis patients. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.116.004961.","journal-title":"J Am Heart Assoc"},{"key":"2011_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1253\/circj.CJ-20-0042","volume":"84","author":"T Yamauchi","year":"2020","unstructured":"Yamauchi T, Yamamoto H, Miyata H, Kobayashi J, Masai T, Motomura N. Surgical aortic valve replacement for aortic stenosis in dialysis patients\u2014analysis of Japan cardiovascular surgery database. Circ J. 2020;84:1271\u20136.","journal-title":"Circ J"},{"key":"2011_CR10","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.amjcard.2017.07.063","volume":"120","author":"S Aljohani","year":"2017","unstructured":"Aljohani S, Alqahtani F, Almustafa A, Boobes K, Modi S, Alkhouli M. Trends and outcomes of aortic valve replacement in patients with end-stage renal disease on hemodialysis. Am J Cardiol. 2017;120:1626\u201332.","journal-title":"Am J Cardiol"},{"key":"2011_CR11","doi-asserted-by":"crossref","unstructured":"Committee for Scientific Affairs TJAfTS, Shimizu H, Endo S, Natsugoe S, Doki Y, Hirata Y et al. Thoracic and cardiovascular surgery in Japan in 2016: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2019;67:377\u2013411.","DOI":"10.1007\/s11748-019-01068-9"},{"key":"2011_CR12","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.jacc.2019.03.496","volume":"73","author":"M Szerlip","year":"2019","unstructured":"Szerlip M, Zajarias A, Vemalapalli S, Brennan M, Dai D, Maniar H, et al. Transcatheter aortic valve replacement in patients with end-stage renal disease. J Am Coll Cardiol. 2019;73:2806\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"2011_CR13","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.athoracsur.2015.05.039","volume":"100","author":"DM Kobrin","year":"2015","unstructured":"Kobrin DM, McCarthy FH, Herrmann HC, Anwaruddin S, Kobrin S, Szeto WY, et al. Transcatheter and surgical aortic valve replacement in dialysis patients: a propensity-matched comparison. Ann Thorac Surg. 2015;100:1230\u20136; discussion 36-7.","journal-title":"Ann Thorac Surg"},{"key":"2011_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2021.07.006","author":"K Maeda","year":"2021","unstructured":"Maeda K, Kuratani T, Mizote I, Hayashida K, Tsuruta H, Takahashi T, et al. One-year outcomes of the pivotal clinical trial of a balloon-expandable transcatheter aortic valve implantation in Japanese dialysis patients. J Cardiol. 2021. https:\/\/doi.org\/10.1016\/j.jjcc.2021.07.006.","journal-title":"J Cardiol"},{"key":"2011_CR15","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1253\/circj.CJ-19-0101","volume":"83","author":"K Maeda","year":"2019","unstructured":"Maeda K, Kuratani T, Mizote I, Shimamura K, Ichibori Y, Onishi T, et al. Midterm outcomes of transcatheter aortic valve replacement in dialysis patients with aortic valve stenosis. Circ J. 2019;83:1600\u20136.","journal-title":"Circ J"},{"key":"2011_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.amjcard.2018.10.008","volume":"123","author":"G Schymik","year":"2019","unstructured":"Schymik G, Bramlage P, Herzberger V, Bergmann J, Conzelmann LO, Wurth A, et al. Impact of dialysis on the prognosis of patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2019;123:315\u201322.","journal-title":"Am J Cardiol"},{"key":"2011_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1845","author":"MR Vindhyal","year":"2018","unstructured":"Vindhyal MR, Ndunda P, Khayyat S, Boppana VS, Fanari Z. Trans-catheter aortic valve replacement and surgical aortic valve replacement outcomes in patients with dialysis: Systematic review and meta-analysis. Cardiovasc Revasc Med. 2018. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1845.","journal-title":"Cardiovasc Revasc Med"},{"key":"2011_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019930","volume":"10","author":"T Ogami","year":"2021","unstructured":"Ogami T, Kurlansky P, Takayama H, Ning Y, Ali ZA, Nazif TM, et al. Long-term outcomes of transcatheter aortic valve replacement in patients with end-stage renal disease. J Am Heart Assoc. 2021;10: e019930.","journal-title":"J Am Heart Assoc"},{"key":"2011_CR19","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jacc.2020.08.049","volume":"76","author":"P Pibarot","year":"2020","unstructured":"Pibarot P, Ternacle J, Jaber WA, Salaun E, Dahou A, Asch FM, et al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 Trial. J Am Coll Cardiol. 2020;76:1830\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"2011_CR20","doi-asserted-by":"publisher","unstructured":"Varc-3 Writing C, Genereux P, Piazza N, Alu MC, Nazif T, Hahn RT et al. Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol. 2021.https:\/\/doi.org\/10.1016\/j.jacc.2021.02.038","DOI":"10.1016\/j.jacc.2021.02.038"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-024-02011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-024-02011-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-024-02011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:14:43Z","timestamp":1731543283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-024-02011-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2011"],"URL":"https:\/\/doi.org\/10.1007\/s11748-024-02011-3","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"type":"print","value":"1863-6705"},{"type":"electronic","value":"1863-6713"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KM and GM report the affiliated department received the scholarship funds from Otsuka Pharmaceutical. Co., Ltd., Century Medical Inc., Medtronic Japan Co., Ltd., Terumo Corp, Japan Lifeline Co., Ltd. KM is a clinical proctor for Edwards Lifesciences. The affiliation of HY and HM is a social collaboration department supported by grants from the National Clinical Database, Johnson & Johnson K.K., and Nipro Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}